title: The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.
authors.affiliation: Department of Pediatric Oncology, Hematology and Immunology, Angelika Lautenschläger Children's Hospital, University of Heidelberg, Heidelberg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Kox
authors.forename: M
authors.initials: M
authors.lastname: Zimmermann
authors.forename: M
authors.initials: M
authors.lastname: Stanulla
authors.forename: S
authors.initials: S
authors.lastname: Leible
authors.forename: M
authors.initials: M
authors.lastname: Schrappe
authors.forename: W-D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: R
authors.initials: R
authors.lastname: Koehler
authors.forename: G
authors.initials: G
authors.lastname: Tolle
authors.forename: O R
authors.initials: OR
authors.lastname: Bandapalli
authors.forename: S
authors.initials: S
authors.lastname: Breit
authors.forename: M U
authors.initials: MU
authors.lastname: Muckenthaler
authors.forename: A E
authors.initials: AE
authors.lastname: Kulozik